Search
Close this search box.

Freshwater bacteria’s vulnerability to climate change due to limited adaptability

Freshwater bacteria play a crucial role in the health and functioning of aquatic ecosystems. These microscopic organisms are responsible for...

Basal stem rot disease, caused by the fungus Ganoderma boninense, is a major threat to the oil palm industry worldwide....

A Texas-based lithium recovery firm has recently announced that they have licensed seven inventions from the Oak Ridge National Laboratory...

Nanotechnology has revolutionized various industries by enabling the manipulation of materials at the atomic and molecular scale. Nanomaterials, which are...

The Treasury Department and the Internal Revenue Service (IRS) have recently released updated guidance on the sustainable aviation fuel tax...

Caterbot and Robatapillar are two popular robotic devices that have gained attention for their ability to navigate loops and bends...

Arthritis is a common condition that affects millions of people worldwide. It is characterized by inflammation and stiffness in the...

A new study has shed light on the groundbreaking work of an 11th century Arab-Muslim optical scientist, whose contributions to...

When it comes to understanding the softness of amorphous materials, one key factor that plays a significant role is the...

Plants are an essential part of our ecosystem, providing oxygen, food, and habitat for countless organisms. But have you ever...

Cytomos, a leading biotechnology company, is set to showcase its groundbreaking new technology, Celledonia™, at the upcoming London Biotechnology Show...

The i3c BRIC-RCB Ph.D. Programme in Biosciences is now accepting applications for the upcoming academic year. This prestigious program, a...

Insilico Medicine, a leading artificial intelligence (AI) drug discovery company, has recently announced that it will be moving its headquarters...

Swiss pharmaceutical giant Novartis recently announced a major investment in a partnership with German biotech company MorphoSys, totaling $3 billion....

Sylvester Cancer Institute, a leading cancer treatment center in Miami, Florida, is at the forefront of incorporating cellular therapy in...

Sylvester Cancer, a leading cancer research and treatment center, is making strides in the fight against metastatic cancer by incorporating...

A recent study conducted by marine biologists has revealed an interesting finding about baby sharks – they prefer staying closer...

In recent years, the healthcare industry has seen a significant shift towards the use of artificial intelligence (AI) to improve...

Organ-on-chips, also known as microphysiological systems, are a cutting-edge technology that has been gaining traction in various industries in recent...

Autonomix Medical Inc. is making waves in the medical industry with its innovative nerve treatment technology, as highlighted in a...

In the pharmaceutical industry, ensuring compliance with regulations and guidelines is of utmost importance. One critical aspect of compliance is...

Sugar processing is a crucial step in the production of various sweeteners and food products. The efficiency of this process...

Studies Study First Submitted Date 2019-03-27 Study First Posted Date 2019-03-29 Last Update Posted Date 2023-04-19 Start Month Year April...

Sanofi, the pharmaceutical company behind the popular heartburn medication Zantac, has reached a resolution in the majority of lawsuits filed...

India has taken a significant step forward in the field of healthcare with the launch of its first home-grown gene...

The Brain & Behavior Research Foundation is a leading non-profit organization dedicated to funding cutting-edge research on mental health disorders....

Biotech Land is a leading company in the field of biotechnology, specializing in the development of innovative products derived from...

Biopharmaceutical companies are constantly seeking ways to improve the efficiency and effectiveness of their clinical trials. One emerging technology that...

In a groundbreaking development for the hemp industry, regulatory clearance has been granted for bioengineered hemp in the latest Bio.News...

Aardvark Therapeutics, a biotechnology company specializing in developing innovative treatments for rare diseases, is gearing up for a $200 million...

James B. Hermiller, MD, MSCAI, appointed as President of SCAI for 2024-25

The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that Dr. James B. Hermiller, MD, MSCAI, has been appointed as President for the 2024-25 term. Dr. Hermiller is a highly respected interventional cardiologist with a wealth of experience in the field of cardiovascular medicine.

Dr. Hermiller currently serves as the Medical Director of Interventional Cardiology at The Care Group in Indianapolis, Indiana. He is also an Associate Clinical Professor of Medicine at Indiana University School of Medicine. Dr. Hermiller has been actively involved in SCAI for many years, serving on various committees and task forces.

In his new role as President of SCAI, Dr. Hermiller will lead the organization in its mission to promote excellence in invasive and interventional cardiovascular medicine. He will work closely with the Board of Trustees and other key stakeholders to advance the field of interventional cardiology through education, research, and advocacy.

Dr. Hermiller’s appointment as President of SCAI is a testament to his dedication and commitment to improving patient care and outcomes in the field of cardiovascular medicine. His leadership and expertise will undoubtedly have a positive impact on the organization and its members.

Under Dr. Hermiller’s guidance, SCAI will continue to be at the forefront of innovation and advancement in interventional cardiology. His vision for the organization includes expanding educational opportunities for members, fostering collaboration among healthcare professionals, and advocating for policies that support high-quality patient care.

As President of SCAI, Dr. Hermiller will be a strong advocate for the field of interventional cardiology and will work tirelessly to ensure that patients receive the best possible care. His leadership will undoubtedly leave a lasting impact on the organization and the field of cardiovascular medicine as a whole.

In conclusion, Dr. James B. Hermiller’s appointment as President of SCAI for the 2024-25 term is a significant milestone for the organization and the field of interventional cardiology. His leadership and expertise will help shape the future of cardiovascular medicine and improve patient outcomes for years to come.